Screener
Denali Therapeutics Inc. DNLI Business Segments — External research and development expense
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept dnli:ExternalResearchAndDevelopmentExpense.
The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:08 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001714899-26-000097
| Line item | Therapeutics Segment / Three Months Ended June 30, 2026 | Therapeutics Segment / Three Months Ended June 30, 2025 | Therapeutics Segment / Six Months Ended June 30, 2026 | Therapeutics Segment / Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Product revenue, net | $3,604 | — | $3,604 | — |
| Less: | ||||
| Cost of goods sold | 93 | — | 93 | — |
| External research and development expenses - TV programs, including cost sharing | 40,419 | 37,594 | 78,883 | 84,052 |
| Other research and development expenses, including small molecule programs | 16,494 | 24,847 | 40,048 | 54,347 |
| Personnel related research and development expenses | 40,106 | 40,255 | 81,934 | 80,524 |
| Total research and development expenses | 97,019 | 102,696 | 200,865 | 218,923 |
| Personnel related selling, general and administrative expenses | 22,921 | 20,115 | 45,485 | 38,853 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Denali Therapeutics Inc.'s business segments — external research and development expense?
- Denali Therapeutics Inc. (DNLI) reported business segments — external research and development expense of $40.42M in Q2 2026.
- What does business segments — external research and development expense mean?
- Represents costs incurred for third-party research and development activities, including payments to external partners or contract research organizations. This metric tracks the company's reliance on external collaboration to advance its therapeutic pipeline. Monitoring these expenses helps investors assess the efficiency of outsourced innovation versus internal development efforts.
Ask your AI about Denali Therapeutics Inc.'s business segments — external research and development expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude